Kriya Therapeutics, Inc.

This #DiabetesAwarenessMonth, we reaffirm our commitment to transforming the treatment of type 1 diabetes and celebrate our dedicated team and fellow researchers who are at the forefront of pioneering innovative solutions for more effective management of this disease. For the 5 million people in the US and EU living with type 1 diabetes, investing in research is key to improving quality of life and delivering better control of their disease. Discover more about our investigational candidate, Kriya-839, a potential one-time gene therapy for type 1 diabetes: https://bit.ly/4huwzSv #GeneTherapy #Type1Diabetes 

Today’s the day! Join us at @Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa to hear our President and Chief Operating Officer, Curt Herberts present on Kriya on Wednesday, October 9th in FLW Ballroom G at 11:30am MST. #genetherapy

Looking forward to attending the H.C. Wainwright & Co., LLC MASH investor conference today. Hope to see you there! 

We are excited for this year’s @Alliance for Regenerative Medicine’s 2024 Cell & Gene Meeting on the Mesa, where our President & Chief Operating Officer, Curt Herberts, will be sharing company highlights during a presentation on October 9th at 11:30am MST.

Join us tomorrow for a fireside chat at RBC Capital Markets Biotechnology Private Company Conference where we’ll share on how we aim to make #genetherapy more accessible to the patients that need it.

We hope to see you at the Bank of America Healthcare Trailblazers Private Company Conference where we will be sharing company updates. 

Join our Chief Gene Therapy Officer, J Fraser Wright, Ph.D., at the 10th Annual World Medical Innovation Forum for a panel discussion about viral vector manufacturing and the delivery of #geneticmedicines. Learn more here: https://bit.ly/3XA5sha

Honored to have our Chief Gene Therapy Officer, J Fraser Wright, Ph.D., speak on the concept of #genetherapy for #diabetes at this year’s transCampus International Roadshow held at King's College London. Learn more: https://bit.ly/3AXUg4V 

We’re participating in the Cantor Fitzgerald Global Healthcare Conference on September 17th where we’ll provide insight into our end-to-end #genetherapy engine and pipeline for prevalent diseases. Hope to see you there!  

We’re presenting data for KRIYA-586, an investigational #genetherapy for #ThyroidEyeDisease today at ESOPRS 42nd Annual Meeting. Preclinical results demonstrate pharmacodynamic activity for KRIYA-586 which encodes for an anti-IGF1R antibody. Learn more here: https://bit.ly/47odtZH #TED